Evidence map›Paper›PMID 30478641›Full record

ArticleThe Psychiatric quarterly2019

Correlates of Negative Attitudes towards Medication in People with Schizophrenia.

Lucie Kondrátová, Daniel König, Karolína Mladá, Petr Winkler

Abstract read
PubMed Publisher
In one paragraph

Article in The Psychiatric quarterly, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Mental health help-seeking by US college students with a diagnosis of psychosis.Social psychiatry and psychiatric epidemiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Lucie KondrátováDepartment of Social Psychiatry, National Institute of Mental Health, Klecany, Czech Republic. lucie.kondratova@nudz.cz.ORCID http://orcid.org/0000-0003-0239-6208
Daniel KönigClinical Division of Social Psychiatry, University-Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
Karolína MladáDepartment of Social Psychiatry, National Institute of Mental Health, Klecany, Czech Republic.
Petr WinklerDepartment of Social Psychiatry, National Institute of Mental Health, Klecany, Czech Republic.
King's College London · GBMedical University of Vienna · ATNational Institute of Mental Health · CZNational Institute of Mental Health · JP

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy (CZ) LO1611
6 · The paper itself

Abstract

Attitudes towards psychiatric medication are an important factor influencing the success of treatment. Mental health care in the region of Central and Eastern Europe remains biologically oriented, yet the attitudes of people with severe mental illnesses are largely unknown. In the present study, we aimed to analyze factors of attitudes toward psychopharmacological drugs among people with schizophrenia spectrum disorder who use community social services in the Czech Republic. Drug Attitude Inventory (DAI) was used as a primary research instrument and data were analyzed using a multivariable linear regression. The majority of respondents (78%) had positive attitudes towards psychopharmacological treatment. Additionally, attitudes towards psychopharmaceutic drugs did not differ with regard to sociodemographic characteristics except for family status. There was a significant negative correlation with the level of self-stigmatization and a significant positive correlation with the duration of treatment. Respondents who had repeated experiences with discontinuation of medication without a prior consultation with a psychiatrist had significantly worse attitudes towards medication than respondents without this experience. This study revealed evidence of a strong relationship between the attitudes toward medication and a history of discontinuation of taking medication and duration of treatment. Therefore, we suggest that interventions focused preventing the internalization of stigmatizing attitudes towards mental illness should be available to people with schizophrenia spectrum disorder, especially in the early stages of the illness - irrespective of the patient's age.

Indexed as

Health Knowledge, Attitudes, PracticePatient CompliancePsychotropic DrugsSchizophreniaSelf ConceptSocial StigmaAdultCross-Sectional StudiesCzech RepublicFemaleHumansMaleMiddle AgedPsychotropic DrugsAdherenceDrug Attitude InventoryPatient compliancePsychotic disordersSchizophrenia

Identifiers

PMID30478641
OpenAlexW2903229565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.